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Abstract
Major depressive disorder (MDD) has been the subject of many neuroimaging case–
control classification studies. Although some studies report accuracies ≥80%, most
have investigated relatively small samples of clinically-ascertained, currently symp-
tomatic cases, and did not attempt replication in larger samples. We here first aimed
to replicate previously reported classification accuracies in a small, well-phenotyped
community-based group of current MDD cases with clinical interview-based diagno-
ses (from STratifying Resilience and Depression Longitudinally cohort, ‘STRADL’). We
performed a set of exploratory predictive classification analyses with measures
related to brain morphometry and white matter integrity. We applied three classifier
types—SVM, penalised logistic regression or decision tree—either with or without
optimisation, and with or without feature selection. We then determined whether
similar accuracies could be replicated in a larger independent population-based sam-
ple with self-reported current depression (UK Biobank cohort). Additional analyses
extended to lifetime MDD diagnoses—remitted MDD in STRADL, and lifetime-
experienced MDD in UK Biobank. The highest cross-validation accuracy (75%) was
achieved in the initial current MDD sample with a decision tree classifier and cortical
surface area features. The most frequently selected decision tree split variables
included surface areas of bilateral caudal anterior cingulate, left lingual gyrus, left
superior frontal, right precentral and paracentral regions. High accuracy was not
achieved in the larger samples with self-reported current depression (53.73%), with
remitted MDD (57.48%), or with lifetime-experienced MDD (52.68–60.29%). Our
results indicate that high predictive classification accuracies may not immediately
translate to larger samples with broader criteria for depression, and may not be
robust across different classification approaches.
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1 | INTRODUCTION
1.1 | Depression
Depression (major depressive disorder, MDD) is a prevalent psychiat-
ric condition which on average affects between 10 and 15% of the
general population over the lifetime in countries around the world
(Bromet et al., 2011; Kessler & Bromet, 2013; Lim et al., 2018). It is
among the leading causes of disability adjusted life years (Vos
et al., 2012), and has been estimated to cost €92 billion in Europe and
$210 billion in the USA in 2010 (Greenberg, Fournier, Sisitsky, Pike, &
Kessler, 2015; Olesen et al., 2012). Depression remains a challenge to
diagnose reliably and recent research indicates a particularly low rate
of diagnostic agreement between specialists (Freedman et al., 2013).
This emphasises the importance of developing better, more reliable
and objective diagnostic methods for the illness.
1.2 | Structural brain differences in depression
In depression, meta-analyses report grey-matter loss (compared to
controls) in frontal and cingulate cortices, as well as subcortical struc-
tures including basal ganglia, thalamus, hippocampus and amygdala
(Arnone et al., 2016; Arnone, McIntosh, Ebmeier, Munafò, &
Anderson, 2012; Bora, Harrison, Davey, Yücel, & Pantelis, 2012;
Kempton et al., 2011; Sacher et al., 2012; Wise et al., 2017). A recent
multi-site study with a large sample (N > 2,000 depression cases) also
suggests significant thinning of cortical grey matter in orbitofrontal
and cingulate cortices, as well as in the insula and temporal lobes in
MDD patients (Schmaal et al., 2017).
With regard to white matter integrity, depression has been found
to be associated with decreased fractional anisotropy (FA) in frontal,
temporal and occipital brain regions, and more specifically in superior
longitudinal fasciculus, uncinate fasciculus, anterior thalamus, medial
forebrain bundle and corpus callosum (Bracht, Linden, & Keedwell,
2015; Chen et al., 2017; Jiang et al., 2017; Liao et al., 2013; Murphy
& Frodl, 2011; Sexton, Mackay, & Ebmeier, 2009; van Velzen
et al., 2019; Wen, Steffens, Chen, & Zainal, 2014). Lower FA and
higher mean diffusivity (MD) are general indications of poorer white
matter organisation and have been associated with depression, as well
as of other psychiatric conditions (Shizukuishi, Abe, & Aoki, 2013).
1.3 | Classification of depression with brain
structural measures
One limitation of group-level findings is that in most cases they cannot
be applied directly for diagnostic purposes. This is because a single
effect identified at group-level may be present in some patients, but
not in others. Moreover, brain regions are organised in networks
(Sporns, 2013), and structural changes in one region can be related to
changes in others (Calhoun, 2018; Xu, Groth, Pearlson, Schretlen, &
Calhoun, 2009). It is hence more promising to combine multiple brain
measures within a machine learning approach for a more accurate diag-
nostic detection (Arbabshirani, Plis, Sui, & Calhoun, 2017). This has
been the subject of depression classification studies outlined below.
Existing studies have used measures derived from structural MRI
and DTI, with depression classification accuracies ranging from 55%
and up to and above 90% (reviews in Gao, Calhoun, & Sui, 2018; Kam-
beitz et al., 2017; Patel, Khalaf, & Aizenstein, 2016). Several studies
with regional cortical thickness, surface area and volume measures
reported cross-validation accuracies between 75 and 80% (Kipli &
Kouzani, 2015; Qiu et al., 2014). Although white matter integrity mea-
sures have seen limited application, several studies have also reported
accuracies close to 75% (Matsuoka et al., 2017; Schnyer, Clasen,
Gonzalez, & Beevers, 2017). Not all investigations have been as suc-
cessful, however. In one study, for example, classification with subcor-
tical grey matter volumes only reached 63% accuracy (Sacchet,
Livermore, Iglesias, Glover, & Gotlib, 2015). In the most recent multi-
site study with independent training and test data sets, Yang
et al. (2018) combined cortical and subcortical volume, cortical thick-
ness and white matter integrity (FA) measures and achieved an accu-
racy of 75%. Specificity (percentage of correctly classified controls in
the test sample), however, only reached modest 32% in this study—
likely due to the smaller number of controls than cases. Samples in all
studies were fairly small, with numbers of cases N < 60 (except for
Yang et al., 2018, where data from N = 147 MDD cases were used for
training and N = 83 for testing). In most studies case and control num-
bers were relatively balanced, with cases and controls also matched
for age and sex. This was an exception for Yang et al. (2018), where
there were three times more cases than controls.
An important limitation of the existing studies is that they did not
investigate what accuracies can be achieved in larger samples with
broader diagnostic criteria, but rather focused on relatively small sam-
ples with formally diagnosed depressed participants (Kambeitz
et al., 2017). Depression is a very common condition and it is unclear
whether high accuracies can generalise from clinically-defined to
community-based samples, which are larger, more heterogeneous,
and typically have less strict diagnostic criteria (Janssen, Mour~ao-
Miranda, & Schnack, 2018; Kim & Na, 2018; Schnack & Kahn, 2016).
1.4 | Study aims
In the current study we first aimed to replicate previously reported
accuracies in depression classification studies within a well-
characterised sample of formally diagnosed currently depressed
participants with brain morphometric (cortical thickness, regional vol-
umes and surface areas) and with white matter integrity (FA and MD)
measures. We aimed to explore several classification techniques and
brain measure subsets to identify the best accuracy that could be
achieved in this well-characterised data set, and to compare the accu-
racy with those of the previous studies. Samples in most previous
studies were balanced, and hence we also aimed to analyse samples
with balanced numbers of cases and controls, and with case and con-
trol participants matched for age and sex.
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Our second aim was to determine if similar accuracies could be
achieved in a larger (N > 700) independent sample with self-reported
current depression. Previous studies have only focused on small sam-
ples with formal diagnoses and in the current study we aimed to
make a novel contribution by testing whether previous results can be
replicated in a large community-based cohort. Community-based
depression is the most prevalent and whether it can be accurately
detected with brain measures remains an important open question,
addressed in this study. In addition to investigating current depres-
sion, we aimed to explore what accuracies can be achieved in larger
samples wit h either remitted or lifetime-experienced depression.
Previous literature did not focus on past depression and we aimed to
fill this gap by testing whether classification accuracies in samples
with these diagnostic criteria could be similar to those with criteria
for current depression.
For each of the investigated diagnostic samples we aimed to test
a number of alternative classification approaches in order to identify
the best approach and the corresponding accuracy. Different classifi-
cation methods are not equivalent and we considered that some may
perform better than others on specific data sets (e.g., Fernández-
Delgado, Cernadas, Barro, & Amorim, 2014).
A more general aim of our study was to make a contribution to
help bridge the gap between the depression research and the applied
machine learning communities, as machine learning techniques are
being increasingly used to investigate clinical populations (Arbabshirani
et al., 2017; Janssen et al., 2018).
2 | MATERIALS AND METHODS
2.1 | Brain measure data sets
Brain measures were taken from two data sets: STRADL (Stratifying
Depression and Resilience Longitudinally, Habota et al., 2019;
Navrady et al., 2018) and UK Biobank (http://www.ukbiobank.ac.uk,
RRID:SCR_012815; Bycroft et al., 2018; Sudlow et al., 2015). Brain
morphometric measures (cortical thickness, cortical surface areas, cor-
tical and subcortical volumes), alongside the relevant demographic
information, were available for N = 622 participants from STRADL
(quality controlled, scanned between June 2015 and August 2017),
and for first and second releases of UK Biobank (N = 8,959 after qual-
ity control, January 2017 release). White matter integrity measures
(FA and MD) were available for N = 873 participants from STRADL
(quality controlled, scanned between June 2015 and January 2019)
and for first through fourth releases of UK Biobank (N = 18,980 after
quality control, October 2018 release). There were less participants
with brain morphometric measures than with white matter integrity
measures because derivation of brain morphometry data required
more manual intervention during quality control in both cohorts.
STRADL received ethical approval from the NHS Tayside committee
on research ethics (reference 14/SS/0039). UK Biobank received ethi-
cal approval from the NHS Research Ethics Committee (reference
11/NW/0382), and the current study received approval from the
UKB Access Committee (application #4844). All participants in both
STRADL and UK Biobank gave written informed consent.
2.1.1 | Brain morphometric measures
In STRADL, T1-weighted imaging was performed at two sites
(Aberdeen and Dundee) with 3T magnetic resonance imaging scanners
(Supplementary section S1.1). N = 650 acquired scans (N = 465
from Aberdeen and N = 185 from Dundee) were processed using
FreeSurfer version 5.3 (http://surfer.nmr.mgh.harvard.edu, RRID:
SCR_001847; Fischl, 2012) and quality-controlled. N = 622 partici-
pants were included after quality control (please see Supplementary
section S1.1.2 for details). Derived brain measures consisted of corti-
cal thickness, cortical surface area and regional volumes for 34 bilateral
cortical regions, as well as volumes for 21 subcortical regions (includ-
ing four cerebellar regions) defined by the Desikan-Killiany atlas
(Desikan et al., 2006), comprising 225 measures in total.
In UK Biobank, T1-weighted imaging data was collected at one
site (Cheadle) with a 3T scanner (Siemens Skyra), following the stan-
dard and freely available UK Biobank imaging and quality control
protocols (Alfaro-Almagro et al., 2018; Smith, Alfaro-Almagro, &
Miller, 2018; UK Biobank, 2014). Brain morphometric measures for
N = 10,109 T1-weighted scans were derived locally with FreeSurfer
version 5.3 and quality controlled (Supplementary section S1.1.3;
Harris et al., 2019; Neilson et al., 2019; Ritchie et al., 2018). After
quality control, measures for N = 8,959 participants were included.
2.1.2 | White matter integrity measures
In STRADL, diffusion-weighted imaging was performed at the same
two sites and with the same scanners as T1-weighted imaging, as part
of a single protocol. FA and MD measures were derived with FSL and
TBSS toolkit for 896 participants (Tract-Based Spatial Statistics,
http://www.fmrib.ox.ac.uk/fsl, RRID:SCR_002823; Smith et al., 2006),
following ENIGMA consortium protocols (http://enigma.ini.usc.edu/
protocols/dti-protocols for FA measures and http://enigma.ini.usc.
edu/protocols/dti-protocols/enigma-dti-diffusivity-protocol/ for MD
measures). Average FA and MD measures were extracted for 19 bilat-
eral and 5 unilateral tracts based on the Johns-Hopkins University
(JHU) white matter atlas (Mori & Crain, 2006)—this resulted in 43 FA
and 43 MD measures in total for each participant. After quality
control, N = 873 participants were included (Supplementary
section S1.1.4).
In UK Biobank, diffusion-weighted imaging was performed
according to the standard UK Biobank imaging protocol (Smith
et al., 2018, sections 2.8 and 2.10). FA and MD measures were
derived for 21 bilateral tracts and six unilateral tracts, resulting in
48 FA and 48 MD measures in total (Mori & Crain, 2006; Smith
et al., 2018, sections 3.10 and 3.10.1). UK Biobank protocol was
slightly different from ENIGMA and there were measures for five
more tracts compared to STRADL. Data for N = 18,980 participants
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were available after quality control by the UK Biobank and after out-
lier exclusion (Supplementary section S1.1.5).
2.1.3 | Correction for confounders
For STRADL data sets, covariates of no interest included age, sex and
scan site. For UK Biobank data sets, covariates included age, sex, scan
site (where appropriate) and three coordinates denoting head position
in the scanner. Correction was performed by residualising each imaging
measure separately over the potential confounder variables—fitting
multiple linear regression model with covariates entered as predictors
and the imaging measure as the response. Residuals of the fitted
models were used as the corrected measures. In order to leverage the
large cohort sizes, this correction was performed on the entire (quality-
controlled) data sets, prior to selection of case–control matched
samples for classification.
2.2 | Diagnostic criteria
A broad range of diagnostic criteria were assessed in order to evaluate
different diagnostic frameworks and depths of phenotyping. Diagno-
ses of current or remitted depression in STRADL were based on clini-
cal interviews and were derived following the DSM criteria (American
Psychiatric Association, 2000). Diagnoses in UK Biobank were based
either on self-report (current or lifetime-experienced symptoms),
or on hospital records (lifetime-experienced depression). For both
STRADL and UK Biobank, we used two types of measures that
respectively assessed (a) cross-sectional, current depression symp-
toms, and (b) lifetime-experienced or remitted depression. Whereas
diagnostic criteria in STRADL were formal interview-based, criteria in
UK Biobank were more lenient as they were mainly based on self-
report (except for hospital-recorded past depression, Table 1). Predic-
tive modelling analyses were performed separately for each of the five
diagnostic definitions across two brain measure domains (brain mor-
phometry and white matter integrity), resulting in 10 sets of analyses
in total. Further details of each of the diagnostic criteria are presented
below and highlighted in Table 1.
2.2.1 | Diagnostic criteria in STRADL
Participants in STRADL were assessed with the research version of
the Structured Clinical Interview for DSM Disorders (SCID, First,
Gibbon, Spitzer, & Williams, 2002; Lobbestael, Leurgans, & Arntz, 2011).
Diagnostic criteria for current MDD (cMDD-STR) or remitted MDD
(rMDD-STR) were based on the diagnostic and statistical manual of
mental disorders (DSM, American Psychiatric Association, 2000). Partici-
pants were considered remitted if they met criteria for at least one past
episode of depression, but did not meet criteria for a current episode.
Participants in STRADL cohort could meet criteria either for current or
remitted MDD, but not for both.
2.2.2 | Diagnostic criteria in UK biobank
In UK Biobank, no formal clinical assessment of depression was made
at the time of the scan. We hence defined participants who were
likely symptomatic at scan-time based on the criteria defined in Smith
et al. (2013), combined with self-reported current symptoms. Briefly,
participants were classed as having probable current MDD (cMDD-
UKB) if they reported low mood or lack of interest lasting 2 weeks at
any time in the past (single-episode or recurrent), history of seeing a
psychiatrist or a GP for nerves, anxiety, tension or depression, and
reported current symptoms relevant to depression according to a
screening assessment at the time of the scan (see Supplementary
section S1.2.2 for screen and exclusion details; Smith et al., 2013; UK
Biobank, 2011). Participants were excluded if they had any major co-
morbid neurological or psychiatric disorder—schizophrenia, bipolar,
multiple personality disorder, autism, intellectual disability, Parkinson's
disease, multiple sclerosis or cognitive impairment.
There were two diagnostic definitions related to lifetime experi-
ence of MDD. The first definition was based on the questions from
Composite International Diagnostic Interview (CIDI-SF, Kessler,
Andrews, Mroczek, Ustun, & Wittchen, 1998), which was adminis-
tered as part of the UK Biobank online mental health questionnaire at
a subsequent time after the imaging assessment (Davis et al., 2019;
UK Biobank, 2017). Briefly, participants were classed as having had
lifetime experience of MDD (past MDD, pMDD-UKB-CIDI) if they
TABLE 1 Summary of the main characteristics of the five investigated diagnostic criteria
Diagnostic
criteria
Current
symptoms
Past
symptoms
Assessment
criteria
Assessment
method
Cases (morphometry/
white matter)
Current
depression
cMDD-STR ✓ - DSM Clinical interview 30/40
cMDD-UKB ✓ ✓ Manually defined Self-report 735/1,435
Past depression rMDD-STR ✕ ✓ DSM Clinical interview 148/202
pMDD-UKB CIDI - ✓ DSM Self-report 1,665/3,418
pMDD-UKB ICD - ✓ ICD Clinical interview 140/289
Note: Tick symbol denotes symptoms were present, dash denotes symptoms could be either present or absent, cross symbol denotes symptoms were absent.
Abbreviations: cMDD-STR, current MDD criteria in STRADL cohort; cMDD-UKB, probable current MDD criteria in UK Biobank cohort; DSM, Diagnostic
and Statistical Manual of Mental Disorders; ICD, International Statistical Classification of Diseases and Related Health Problems; pMDD-UKB-CIDI, lifetime
MDD criteria based on the online Composite International Diagnostic Interview (CIDI) in UK Biobank cohort; pMDD-UKB-ICD, lifetime MDD criteria
based on ICD and hospital records in UK Biobank cohort; rMDD-STR, remitted MDD criteria in STRADL cohort.
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reported experiencing one or more depressive episodes in their life
according to the DSM criteria (American Psychiatric Association,
2000). Participants were excluded from control sample for pMDD-
UKB-CIDI definition if they were likely to have experienced depres-
sion (Supplementary section S1.2.3). Assessment in pMDD-UKB-CIDI
definition was similar to SCID, but administered as part of an online
questionnaire.
The second diagnostic definition for lifetime MDD was derived
from medical records and was based on a formal past diagnosis of
depression, made by a clinician in a hospital setting according to the
ICD criteria (pMDD-UKB-ICD; UK Biobank, 2019; World Health
Organisation, 1992; Supplementary section S1.2.4). Because medical
records were not available for all participants in the UK Biobank, some
pMDD-UKB-ICD cases may have been missed. Participants were
excluded from control sample for this definition if they self-reported
past experience of mood disorder.
Two definitions of ‘lifetime-experienced’ MDD were studied
because we assumed that there could be differences between self-
reported and formally clinically-assessed experience of depression.
The main difference between the diagnostic criteria for lifetime expe-
rience of MDD (UK Biobank) and remitted MDD (STRADL) was that
participants meeting lifetime criteria could have an ongoing episode,
while those with remitted MDD could not. Our rationale was to check
if slight differences in assessment and inclusion criteria between these
three samples with past depression could lead to different classifica-
tion outcomes. It should be noted that participants in UK Biobank
could meet criteria for more than one diagnostic definition—cases in
pMDD-UKB-CIDI and pMDD-UKB-ICD, as well as cMDD-UKB sam-
ples could overlap between each other.
2.3 | Matched sample selection
Selection of age and sex matched cases and controls was performed
primarily to enable balanced class data for classifier training and testing.
Tables 2 and 3 outline the numbers and main demographic characteris-
tics of participants who met criteria for each of the five defined diag-
nostic definitions, with brain morphometric and white matter integrity
measures respectively (between N = 140 and N = 3,418 cases in each
sample). For each case participant from cMDD-STR and rMDD-STR
samples, we selected a control with no history of depression, matched
by handedness, sex and scan site, and with the smallest difference in
age. It is worth highlighting that control samples were drawn to have
minimal difference with cases with regard to demographic criteria (par-
ticularly age) and were thus non-random. For each case participant
from UK Biobank (cMDD-UKB, pMDD-UKB-CIDI and pMDD-UKB-
ICD samples), we selected a control with the same sex and scan site,
and the smallest age difference. Importantly, there were N > 700 cases
TABLE 2 Summary demographic
information for cases and controls in the
five analysed samples with brain
morphometric measures (cortical
thickness, surface areas, and volumes)
Sample Characteristic Controls Cases
Current depression cMDD-STR Size 30 30
Sex (male/female) 8/22 8/22
Age (years) 54.23 (10.98) 54.07 (10.96)
QIDS 3.3 (2.25) 13.97 (3.59)
Medicated 2 18
cMDD-UKB Size 735 735
Sex (male/female) 215/520 215/520
Age (years) 59.66 (7.21) 59.66 (7.21)
Past depression rMDD-STR Size 148 148
Sex (male/female) 44/104 44/104
Age (years) 58.06 (8.02) 57.16 (8.81)
QIDS 3.49 (2.35) 5.48 (3.91)
pMDD-UKB-CIDI Size 1,665 1,665
Sex (male/female) 544/1,121 544/1,121
Age (years) 60.91 (7.18) 60.90 (7.19)
pMDD-UKB-ICD Size 140 140
Sex (male/female) 49/91 49/91
Age (years) 61.59 (7.64) 61.59 (7.65)
Note: Standard deviations for age and QIDS are in brackets. In cMDD-STR sample participants were con-
sidered medicated if they had at least one antidepressant prescription.
Abbreviations: cMDD-STR, current MDD criteria in STRADL cohort; cMDD-UKB, probable current MDD
criteria in UK Biobank cohort; pMDD-UKB-CIDI, lifetime MDD criteria based on the online Composite
International Diagnostic Interview (CIDI) in UK Biobank cohort; pMDD-UKB-ICD, lifetime MDD criteria
based on ICD and hospital records in UK Biobank cohort; QIDS, Quick Inventory of Depressive
Symptomatology; rMDD-STR, remitted MDD criteria in STRADL cohort.
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with self-reported current depression in UK Biobank (cMDD-UKB sam-
ple), which is significantly more than in the previous depression classifi-
cation studies (Gao et al., 2018; Kambeitz et al., 2017).
2.4 | Predictive modelling
Predictive modelling was performed separately with brain morphomet-
ric data and with white matter integrity data—there were therefore
10 matched case–control data sets (five diagnostic definitions across
two feature domains). For each of the 10 data sets we performed
either leave-one-out (LOOCV), 10-fold or fivefold cross-validation,
depending on the size of the data set. Cross-validation was attempted
separately with three classifier models, with different feature sub-
domains (e.g., all brain morphometric measures or only cortical thick-
ness, surface area, volume or subcortical measures), with or without
classifier hyperparameter optimisation, and with or without feature
selection (e.g., Patel et al., 2015; Qiu et al., 2014; Schnyer et al., 2017;
Yang et al., 2018). Where feasible, cross-validation was repeated mul-
tiple times with different fold partitions. Cross-validation accuracies,
sensitivities, specificities and area under receiver operating character-
istic curve (ROC AUC, Melo, 2013) were recorded for each analysis to
identify classification approaches with the best results.
2.4.1 | Classification models and optimisation
We explored three classification models—support vector machine
with a Gaussian kernel (SVM, Cortes & Vapnik, 1995; Hofmann,
Schölkopf, & Smola, 2008), penalised logistic regression (PLR,
Zou & Hastie, 2005), and the simple decision tree (DT, Kingsford &
Salzberg, 2008). SVM was chosen because of wide use of the tech-
nique in previous neuroimaging classification studies with some
success (Arbabshirani et al., 2017; Kambeitz et al., 2017; Patel
et al., 2016). PLR was selected because it is a linear classifier and
has been shown to perform well in some previous studies with neu-
roimaging data (e.g., Dadi et al., 2019). DT was applied because of
its low computational complexity and suitability for data sets with
relatively small numbers of features. Classifier training and testing
was performed with MATLAB R2015b Statistics and Machine
Learning Toolbox (http://www.mathworks.com/products/matlab/,
Mathworks Inc, RRID:SCR_001622).
Classification with SVM and DT classifiers was attempted
both with and without hyperparameter optimisation. PLR model
always requires hyperparameter optimisation. Further details on
the specified fixed hyperparameter values and hyperparameter
search grids can be found in Supplementary sections S1.3.2
and S1.3.3.
TABLE 3 Summary demographic
information for cases and controls in the
five analysed samples with white matter
integrity measures (FA and MD)
Sample Characteristic Controls Cases
Current depression cMDD-STR Size 40 40
Sex (male/female) 10/30 10/30
Age (years) 55.03 (9.77) 54.23 (10.35)
QIDS 3.58 (2.54) 14.13 (3.88)
Medicated 2 28
cMDD-UKB Size 1,435 1,435
Sex (male/female) 451/984 451/984
Age (years) 60.11 (7.16) 60.11 (7.16)
Past depression rMDD-STR Size 202 202
Sex (male/female) 56/146 56/146
Age (years) 57.89 (8.84) 56.97 (9.28)
QIDS 3.53 (2.36) 5.38 (3.68)
pMDD-UKB-CIDI Size 3,418 3,418
Sex (male/female) 1,094/2,324 1,094/2,324
Age (years) 61.46 (7.09) 61.44 (7.11)
pMDD-UKB-ICD Size 289 289
Sex (male/female) 97/192 97/192
Age (years) 61.77 (7.70) 61.76 (7.70)
Note: Standard deviations for age and QIDS are in brackets. In cMDD-STR sample participants were
considered medicated if they had at least one antidepressant prescription.
Abbreviations: cMDD-STR, current MDD criteria in STRADL cohort; cMDD-UKB, probable current MDD
criteria in UK Biobank cohort; pMDD-UKB-CIDI, lifetime MDD criteria based on the online Composite
International Diagnostic Interview (CIDI) in UK Biobank cohort; pMDD-UKB-ICD, lifetime MDD criteria
based on ICD and hospital records in UK Biobank cohort; QIDS, Quick Inventory of Depressive
Symptomatology; rMDD-STR, remitted MDD criteria in STRADL cohort.
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2.4.2 | Feature selection
Two feature selection methods were attempted with SVM and decision
tree classifiers. The methods were a t-test filter and a wrapper method
based on sequential feature elimination (Aha & Bankert, 1996; Mwangi,
Tian, & Soares, 2014). Filter feature selection is widely used in neuroim-
aging classification studies (Kambeitz et al., 2017; Mwangi et al., 2014;
Patel et al., 2016), while sequential feature elimination was applied
because it offers more extensive exploration of feature space compared
to other methods, and counts of features in our study (less than 250 in
all analyses) enabled its application with reasonable computation times.
Sequential feature elimination is very computationally expensive and
we only applied it with fixed sets of hyperparameters (no combined
hyperparameter optimisation). In PLR classification, feature selection is
already embedded through elastic net regularisation (Zou &
Hastie, 2005) and no additional feature selection was performed.
Sequential feature elimination was not performed in cMDD-UKB
and pMDD-UKB-CIDI samples with combined brain morphometric
feature set and decision tree classifier, due to large sample sizes and
high computational complexity (Supplementary section S2.2). Further
details on the applied feature selection methods can be found in Sup-
plementary sections S1.3.4 and S1.3.5.
2.4.3 | Cross-validation
In analyses with cMDD-STR diagnostic definition we applied LOOCV
due to the small data set size (N = 60 participants with morphometric
brain measures and N = 80 participants with white matter integrity
measures)—in order to maximise the amount of training data. In all
other analyses we used 10-fold cross-validation, with an exception for
pMDD-UKB-CIDI data set of white matter integrity measures.
pMDD-UKB-CIDI white matter integrity data set was the largest
(N = 6,836 participants) and we applied fivefold cross-validation to
enable classifier training and optimisation in reasonable time. Cross-
validation was repeated 10 times with pre-determined random fold
partitions for each classification approach in smaller data sets (rMDD-
STR and pMDD-UKB-ICD diagnostic criteria). This was not feasible
for the larger data sets due to long optimisation times (cMDD-UKB
and pMDD-UKB-CIDI diagnostic criteria), and hence cross-validation
was performed only once with a single predefined partition. Fold par-
titions for the larger data sets were deterministically defined with an
algorithm which aimed to maximally balance cross-validation folds
with respect to age and sex (Supplementary section S1.3.6).
2.4.4 | Comparison of classification methods
To compare classification approaches we applied either corrected
paired t-tests (rMDD-STR and pMDD-UKB-ICD data sets, Bouckaert &
Frank, 2004; Nadeau & Bengio, 2003), or McNemar's test (cMDD-UKB
and pMDD-UKB-CIDI data sets, McNemar, 1947). Each approach was
given a relative score according to the number of approaches which
performed worse. Further details on comparison of classification
methods can be found in Supplementary section S1.3.7.
2.4.5 | Case–control differences
In addition to predictive modelling, we checked for case–control dif-
ferences in the 10 evaluated samples using simple two-sample t tests
with corrections for false discovery rate (Benjamini & Hochberg,
1995). Results for these analyses are reported in Supplementary
section S2.1.
3 | RESULTS
To summarise, accuracies above 60% were only achieved in the small
current MDD sample from STRADL (best accuracy 75% with brain
morphometric features and 61.25% with white matter integrity fea-
tures, Tables 4 and 5). Best accuracies across all classification
attempts in samples with all other diagnostic criteria were between
52.68 and 60.29%, and are summarised in Table 6.
3.1 | Classification of current MDD and controls
Top classification accuracy in the small cMDD-STR sample was 75%
(sensitivity 80%, specificity 70%, ROC AUC 0.68) with all surface
area features and the simple decision tree classifier, no hyper-
parameter optimisation, and no feature selection. Importance of
each feature in this analysis can be defined by the fraction of cross-
validation folds where the feature was selected as one of decision
tree cut variables. Surface area features with highest contribution
according to this criteria are illustrated in Figure 1—these included
right paracentral and precentral regions (selected in all folds), right
caudal anterior cingulate (54 of 60 folds), left lingual gyrus (51 of
60 folds), left caudal anterior cingulate (28 of 60 folds), and left
superior frontal region (26 of 60 folds). We additionally assessed fea-
ture contributions to the best classification accuracy by excluding
one feature at a time and assessing drops in cross-validation accu-
racy. Top contributing features according to this criteria were the
four most important in Figure 1—right precentral (accuracy drop
23.3%), right paracentral (20%), left lingual (10%) and right caudal
anterior cingulate (8.3%) regions.
Classification accuracy decreased from 75 to 68.33% (sensitivity
70.00%, specificity 66.67%, ROC AUC 0.637) with added sequential
feature elimination and with hyperparameter optimisation it reached
65% (sensitivity 76.67%, specificity 53.33%, ROC AUC 0.677). This
could be indicative of optimisation-related over-fitting. Accuracies with
all other feature domains with DT classifier were below 60%. With
SVM classifier, top accuracy reached 63.33% with all thickness features
(no optimisation or feature selection; sensitivity 63.33%, specificity
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63.33%, ROC AUC 0.682). Accuracies for all classification attempts
with morphometric brain measures in cMDD-STR sample can be
found in Table 4.
For white matter integrity measures, top accuracy reached
61.25% (sensitivity 57.50%, specificity 65%, ROC AUC 0.673) with
SVM classifier, all MD features and hyperparameter grid search.
TABLE 4 Case-control classification accuracies and ROC AUC measures (on cross-validation) with brain morphometric features in cMDD-
STR sample (30 cases and 30 controls)
Classifier
type
Feature
selection
Hyperparam.
optimisation Outer CV Inner CV Feature domain
Classification accuracy
(sensitivity/specificity)
ROC
AUC
PLR Embedded Grid search LOOCV 10-fold Thickness 60.00% (56.67/63.33%) 0.609
Surface area 51.67% (50.00/53.33%) 0.547
Volume 56.67% (60.00/53.33%) 0.539
Subcortical 55.00% (56.67/53.33%) 0.572
Combined 50.00% (46.67/53.33%) 0.546
SVM None None LOOCV - Thickness 63.33% (63.33/63.33%) 0.682
Surface area 46.67% (43.33/50.00%) 0.529
Volume 51.67% (40.00/63.33%) 0.550
Subcortical 60.00% (60.00/60.00%) 0.582
Combined 61.67% (70.00/53.33%) 0.568
Grid search LOOCV Thickness 60.00% (60.00/60.00%) 0.556
Surface area 50.00% (46.67/53.33%) 0.500
Volume 61.67% (50.00/73.33%) 0.649
Subcortical 58.33% (50.00/66.67%) 0.602
Combined 58.33% (63.33/53.33%) 0.628
Statistical filter None Combined 53.33% (40.00/66.67%) 0.540
Grid search 10-fold Combined 45.00% (40.00/50.00%) 0.513
Sequential
elimination
None Thickness 61.67% (56.67/66.67%) 0.687
Surface area 48.33% (43.33/53.33%) 0.519
Volume 50.00% (36.67/63.33%) 0.556
Subcortical 53.33% (50.00/56.67%) 0.573
Combined 61.67% (63.33/60.00%) 0.659
DT None None LOOCV - Thickness 38.33% (40.00/36.67%) 0.283
Surface area 75.00% (80.00/70.00%) 0.680
Volume 45.00% (43.33/46.67%) 0.377
Subcortical 43.33% (46.67/40.00%) 0.394
Combined 55.00% (50.00/60.00%) 0.473
Grid search LOOCV Thickness 51.67% (53.33/50.00%) 0.318
Surface area 65.00% (76.67/53.33%) 0.677
Volume 46.67% (46.67/46.67%) 0.442
Subcortical 58.33% (56.67/60.00%) 0.500
Combined 38.33% (46.67/30.00%) 0.407
Statistical filter None Combined 33.33% (43.33/23.33%) 0.189
Grid search 10-fold Combined 43.33% (43.33/43.33%) 0.350
Sequential
elimination
None Thickness 35.00% (46.67/23.33%) 0.255
Surface area 68.33% (70.00/66.67%) 0.637
Volume 40.00% (40.00/40.00%) 0.292
Subcortical 51.67% (46.67/56.67%) 0.426
Combined 63.33% (56.67/70.00%) 0.533
Note: Top accuracies for SVM, PLR and DT classifiers are in italics.
Abbreviations: CV, cross-validation; DT, decision tree; LOOCV, leave-one-out cross-validation; PLR, penalised logistic regression; ROC AUC, receiver operating
characteristic area under the curve; SVM, support vector machine.
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Accuracies for all other optimisation attempts were below 58% and
are outlined in Table 5.
We performed additional analyses to check if the best classifica-
tion accuracy can be replicated with a different set of controls. The
alternative set of controls was again matched to cases by age and
sex, although matching for age was slightly worse compared to the
original sample. The previous best approach (decision tree with sur-
face area features) with added sequential feature elimination
reached 61.67% accuracy (sensitivity 63.33%, specificity 60%, ROC
AUC 0.501), which was the best for the sample. Similar accuracy was
achieved with SVM with hyperparameter grid search and cortical
thickness features (sensitivity 60%, specificity 63.33%, ROC AUC
0.57), and with PLR classifier and combined feature set (sensitivity
63.33%, specificity 60%, ROC AUC 0.648). Results for the original
best approach without added sequential feature elimination were
not replicated (accuracy 50%, sensitivity 60%, specificity 40%, ROC
AUC 0.438). Details of these analyses can be found in Supplemen-
tary section S2.2.
TABLE 5 Case-control classification accuracies and ROC AUC measures (on cross-validation) with white matter integrity features in the
cMDD-STR sample (40 cases and 40 controls)
Classifier
type
Feature
selection
Hyperparam
optimisation
Outer
CV
Inner
CV
Feature
domain
Classification accuracy
(sensitivity/specificity)
ROC
AUC
PLR Embedded Grid search LOOCV 10-fold FA 31.25% (35.00/27.50%) 0.363
MD 53.75% (55.00/52.50%) 0.589
Combined 48.75% (50.00/47.50%) 0.474
SVM None None LOOCV - FA 48.75% (40.00/57.50%) 0.484
MD 57.50% (55.00/60.00%) 0.536
Combined 52.50% (50.00/55.00%) 0.520
Grid search LOOCV FA 50.00% (40.00/60.00%) 0.505
MD 61.25% (57.50/65.00%) 0.673
Combined 53.75% (52.50/55.00%) 0.559
Statistical filter None FA 40.00% (32.50/47.50%) 0.345
MD 37.50% (30.00/45.00%) 0.353
Combined 30.00% (20.00/40.00%) 0.283
Grid search 10-fold FA 52.50% (60.00/45.00%) 0.476
MD 38.75% (40.00/37.50%) 0.385
Combined 38.75% (40.00/37.50%) 0.328
Sequential elimination None FA 47.50% (40.00/55.00%) 0.488
MD 53.75% (52.50/55.00%) 0.534
Combined 51.25% (55.00/47.50%) 0.501
DT None None LOOCV - FA 53.75% (50.00/57.50%) 0.434
MD 56.25% (55.00/57.50%) 0.514
Combined 57.50% (42.50/72.50%) 0.552
Grid search LOOCV FA 48.75% (65.00/32.50%) 0.350
MD 47.50% (40.00/55.00%) 0.372
Combined 51.25% (47.50/55.00%) 0.563
Statistical filter None FA 45.00% (35.00/55.00%) 0.323
MD 43.75% (30.00/57.50%) 0.331
Combined 36.25% (30.00/42.50%) 0.256
Grid search 10-fold FA 42.50% (47.50/37.50%) 0.280
MD 40.00% (35.00/45.00%) 0.204
Combined 33.75% (35.00/32.50%) 0.267
Sequential elimination None FA 48.75% (45.00/52.50%) 0.433
MD 52.50% (52.50/52.50%) 0.458
Combined 56.25% (55.00/57.50%) 0.488
Note: Top accuracies for SVM, PLR and DT classifiers are in italics.
Abbreviations: CV, cross-validation; DT, decision tree; LOOCV, leave-one-out cross-validation; PLR, penalised logistic regression; ROC AUC, receiver operating
characteristic area under the curve; SVM, support vector machine.
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3.2 | Classification of self-reported current
depression and controls in large UKB sample
High classification accuracies were not replicated in the large population-
based sample with self-reported current depression (cMDD-UKB). Top
accuracy for the data set with brain morphometric measures only
reached 52.80% (sensitivity 52.66%, specificity 52.92%, ROC AUC
0.540) with PLR classifier (hyperparameter optimisation and embedded
feature selection) and cortical thickness features. Top accuracy with
white matter integrity measures was 53.73% (sensitivity 51.08%, speci-
ficity 56.37%, ROC AUC 0.549) with SVM classifier, combined FA and
MD features and sequential feature elimination. Accuracies and scores
for each classification approach can be found in Tables S12 and S16.
3.3 | Classification of remitted MDD and controls
Top accuracy in rMDD-STR sample with brain morphometric
measures reached 57.48% (sensitivity 52.57%, specificity
62.35%, ROC AUC 0.572) with decision tree classifier, hyper-
parameter grid search, filter feature selection and combined
feature set (best approach score of 13 of maximal 37). This
was closely followed by decision tree without optimisation or
feature selection (accuracy 57.09%, sensitivity 56.64%, specific-
ity 57.47%, ROC AUC 0.591, score 11). Accuracies for all other
classification attempts with brain morphometric measures were
lower than 56% and can be found alongside the related scores
in Table S11.
Top accuracy with white matter integrity measures was
55.54% (sensitivity 59.16%, specificity 51.92%, ROC AUC 0.560)
with SVM, all MD features and hyperparameter grid search (classifi-
cation approach score second-best with 6 of 28). This was closely
followed by PLR classifier with accuracy 55.15% (sensitivity
53.48%, specificity 56.78%, ROC AUC 0.560, score 7), and SVM
with no optimisation or feature selection (accuracy 55.08%, sensi-
tivity 54.23%, specificity 55.90%, score 6). Accuracies for all other
classification attempts were below 55% and can be found in
Table S15.
TABLE 6 Best accuracies and related ROC AUC measures for case-control classification (on cross-validation) for brain moprhometric and
white matter integrity features in cMDD-UKB, rMDD-STR, pMDD-UKB-CIDI, and pMDD-UKB-ICD samples
Data set Feature domain
Sample
size Classification approach
Classification accuracy
(sensitivity/specificity)
ROC
AUC
cMDD-UKB Cortical thickness features 1,470 PLR classifier
- Hyperparameter grid search
- Embedded feature selection
52.80% (52.66/52.92%) 0.540
Combined FA and MD features 2,870 SVM classifier
- No hyperparameter optim.
- Sequential feat. Elimination
53.73% (51.08/56.37%) 0.549
rMDD-STR Combined brain morphometric
features
296 Decision tree classifier
- Hyperparameter grid search
- Filter feature selection
57.48% (52.57/62.35%) 0.572
MD features 404 SVM classifier
- Hyperparameter grid search
- No feature selection
55.54% (59.16/51.92%) 0.560
pMDD-UKB-CIDI Cortical thickness features 3,330 SVM classifier
- No hyperparameter optim.
- No feature selection
53.63% (53.72/53.54%) 0.532
Combined FA and MD features 6,836 SVM classifier
- 5-fold inner/outer CV
- No hyperparameter optim.
- Sequential feat. Elimination
52.68% (53.63/51.73%) 0.531
pMDD-UKB-ICD Combined brain morphometric
features
280 PLR classifier
- Hyperparameter grid search
- Embedded feature selection
60.29% (61.86/58.71%) 0.645
MD features 578 SVM classifier
- No hyperparameter optim.
- Filter feature selection
56.18% (68.56/43.83%) 0.566
Note: Combined brain morphometric features included cortical thickness, surface area, cortical and subcortical volume measures. Nested 10-fold outer and
10-fold inner cross-validation was performed in all analyses, except where otherwise specified. Top two accuracies are in italics.
Abbreviations: cMDD-UKB, sample with probable current MDD in UK Biobank cohort; FA, fractional anisotropy; MD, mean diffusivity; PLR, penalised
logistic regression; pMDD-UKB-CIDI, sample with lifetime MDD based on the online Composite International Diagnostic Interview (CIDI) criteria in UK
Biobank cohort; pMDD-UKB-ICD, sample with lifetime MDD based on the ICD criteria and hospital records in UK Biobank cohort; rMDD-STR, sample
with remitted MDD in STRADL cohort; ROC AUC, receiver operating characteristic area under the curve; SVM, support vector machine.
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3.4 | Classification of lifetime-experienced
MDD and controls
3.4.1 | Classification of self-reported lifetime
MDD and controls
Top accuracy in pMDD-UKB-CIDI sample with brain morphometric
features was 53.63% (sensitivity 53.72%, specificity 53.54%, ROC
AUC 0.532) with SVM classifier, no optimisation or feature selection
and cortical thickness features. Top accuracy with white matter integ-
rity measures was only 52.68% (sensitivity 53.63%, specificity
51.73%, ROC AUC 0.531) with SVM and sequential feature elimina-
tion on combined set of FA and MD measures. Accuracies for all other
classification attempts were lower and can be found alongside scores
for each approach in Tables S13 and S17.
3.4.2 | Classification of hospital-recorded lifetime
MDD and controls
Top accuracy for the pMDD-UKB-ICD sample with brain morphomet-
ric measures reached 60.29% (sensitivity 61.86%, specificity 58.71%,
ROC AUC 0.645) with PLR classifier and combined feature set (best
score of 20 out of maximal 37). Accuracies for all other classification
attempts with brain morphometric measures were below 59% and can
be found alongside scores for each approach in Table S14.
Top accuracy with white matter integrity measures was 56.18%
(sensitivity 68.56%, specificity 43.83%, ROC AUC 0.566) with SVM
classifier, MD features and filter feature selection (best score of 12 of
maximal 31). All other accuracies for the sample were below 56% and
can be found together with scores for each approach in Table S18.
4 | DISCUSSION
4.1 | Classification of current depression
4.1.1 | Classification accuracy
The best classification accuracies were achieved in the small sam-
ple with formally-diagnosed current MDD (cMDD-STR, 75% with
decision tree and surface area features; 61.25% with MD features
and SVM classifier with optimised hyperparameters). These results
are broadly consistent with those of previous studies with similar
feature domains, where best accuracies were between 60 and
80% (Kipli & Kouzani, 2015; Matsuoka et al., 2017; Qiu et al.,
2014; Sacchet et al., 2015; Schnyer et al., 2017; Yang et al.,
2018). MD features in the study appeared more discriminative of
F IGURE 1 Surface area regions consistently selected as decision tree cut features across cross-validation folds in cMDD-STR sample. Colour
of each region indicates fraction of folds where surface area of the region was selected as one of the cut variables. Regions in dark grey were
never selected. Most frequently selected regions include bilateral caudal anterior cingulate, left lingual gyrus, left superior frontal, right precentral
and paracentral regions
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current MDD than FA features (Table 5), which is consistent with
some of the previous work in our lab (Barbu et al., 2019; Shen
et al., 2019).
It could be highlighted that combination of feature subsets almost
never outperforms the subsets applied individually, even with feature
selection or regularisation (Tables 4 and 5). This could be because the
feature subsets contain more non-overlapping redundant information
compared to complementary depression-relevant information (for
example volume measures depend on both surface area and cortical
thickness measures), and thus combining them does not aid in
classification.
The best accuracy of 75% was not replicated when the control
sample was replaced, although a similar classification approach
achieved an accuracy of 61.67% (Table S19). This could in part be due
to the fact that the replaced controls were slightly less well matched
to cases with respect to age. On the other hand, it is likely that non-
depressed control participants are heterogeneous and some may be
better discriminated from depressed participants than others.
4.1.2 | Predictive brain regions
Six surface area measures were identified as the most predictive of
current MDD (Figure 1). Decreases in grey matter in precentral cortex
were previously reported in several studies (Grieve, Korgaonkar,
Koslow, Gordon, & Williams, 2013; Zhang et al., 2012), although
reductions in surface area in this region were reported more specifi-
cally for adolescent depression (Schmaal et al., 2017). Anterior cingu-
late cortex has long been theorised to play an important role in MDD
due to its involvement in processing of reward and emotional informa-
tion (Diener et al., 2012; Holroyd & Umemoto, 2016; Rolls, 2016);
brain structural studies do indeed show changes in this region, as well
as in the adjacent superior frontal cortex (Grieve et al., 2013; Li
et al., 2020; Schmaal et al., 2017; Zhao et al., 2017). For lingual gyrus,
increased grey-matter volume was reported in late-life and late-onset
depression (Ancelin et al., 2019; Du et al., 2014), but surface area
reductions were found in adolescent depression (Schmaal et al., 2017).
These regions are, of course, only a subset of those identified as altered
in MDD and others include the wider frontal cortex and the subcortical
structures including the amygdala, hippocampus and the thalamus
(Arnone et al., 2016; Wise et al., 2017). It is likely that the current MDD
cases in our study represent a subtype of depression characterised
by changes in the identified regions and that other subtypes may
be characterised by different patterns of changes in the brain.
4.2 | Classification of self-reported current
depression in larger population sample
The core novel contribution of our study is in attempted classification
of depression in the comparatively very large community-based UK
Biobank sample (cMDD-UKB). There were N = 735 cases in the data
set of brain morphometric measures and N = 1,435 cases in the data
set of white matter integrity measures (Tables 2 and 3), which is sig-
nificantly larger than in most previous depression classification studies
(Gao et al., 2018; Kambeitz et al., 2017). High accuracies were not
replicated in this sample (Tables 6, S12 and S16) which indicates that
community-based depression, which is the most prevalent, cannot be
accurately detected using structural brain measures.
Consistent with our findings, recent reviews indicate that the
highest accuracies to date have only been achieved in imaging classifi-
cation studies with small samples (N < 100 participants), and that
accuracy tends to decrease with larger sample sizes (Arbabshirani
et al., 2017; Janssen et al., 2018). Kim and Na (2018) highlight that
because most studies focus on small and relatively homogeneous
samples, best results may not immediately translate to real-world set-
tings with large heterogeneous depressed populations, due to factors
such as co-morbidities, medication, differences in illness severity and
recurrence, and clinical subtypes. In addition, other factors such as
multiple scanning sites and difficulties with managing artefacts in large
data sets may also be at play (e.g., Johnston, Mwangi, Matthews,
Coghill, & Steele, 2013). Our results underscore importance of these
points—high accuracies were only found in the small cMDD-STR sam-
ple, were not replicated in larger samples, and best accuracies tended
to decrease towards chance level with increasing sample size
(Figure 2).
Apart from the large sample size and the resulting heterogeneity,
one factor which may have contributed to the lower accuracies is the
difference in the diagnostic criteria. There were no formal diagnoses
at scan time for UK Biobank participants and the current depression
diagnoses were based on self-reported past and current symptoms
(Supplementary section S1.2.2). These criteria arguably correspond to
less severe forms of depression, more prevalent in community set-
tings. Less severe depression is likely to have fewer and weaker asso-
ciations with changes in brain structure, which in turn may have
contributed to lower classification accuracies.
F IGURE 2 Best classification accuracies plotted against sample
sizes for all 10 analysed samples (five diagnostic definitions across two
feature domains—brain morphometry and white matter integrity). Best
accuracy tended to decrease towards chance level with increasing
sample size. Sample size/abscissa axis logarithmically scaled.
Abbreviation: ROC AUC, receiver operating characteristic area under
the curve
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4.3 | Classification of remitted or lifetime-
experienced depression
The second novel contribution of our study is attempted classifica-
tion of depression in samples with diagnostic criteria related to past
depression (remitted or lifetime-experienced). Top two accuracies
were 60.29% for pMDD-UKB-ICD diagnostic definition, and 57.48%
for rMDD-STR definition, with all brain morphometric features
(Table 6). Previous classification literature did not study past depres-
sion, but indicates that the best accuracies can be achieved in sam-
ples with severe and chronic/treatment-resistant ongoing episodes
(e.g., Johnston, Steele, Tolomeo, Christmas, & Matthews, 2015;
Mwangi, Ebmeier, Matthews, & Steele, 2012). These are typically
patients who are medicated and seen long-term in clinical care, but
who are studied less often due to long time and resources necessary
for recruitment. In a recent review, Kambeitz et al. (2017) highlight
that current symptom severity (as measured by Hamilton Depression
Rating Scale, Hamilton, 1980) could predict better classification out-
comes across 33 analysed studies, covering both brain structural and
functional feature modalities (e.g., task-related and resting-state
brain activation; Johnston et al., 2015; Zeng et al., 2012). Our results
extend the previous literature and suggest that, compared to current
depression, cases with past depression are even more difficult to
discriminate from healthy controls based on structural brain
measures.
It is worth highlighting that participants with past depression in
our study were of relatively older age (mean ages 57–62, Tables 2 and
3). With increasing age brain structure may be influenced more by
medications, cardio-vascular health, lifestyle and other factors, which
may in turn impact how depression affects the brain. Future research
could take these factors into account when classifying past or present
depression in older age.
4.4 | Classification methods
Selection of classification methods in our study was guided by the
previous neuroimaging literature and computational complexity con-
siderations. SVM, decision tree and penalised logistic regression are
among the most promising classifiers based on the previous studies
(Arbabshirani et al., 2017; Dadi et al., 2019; Fernández-Delgado
et al., 2014; Kambeitz et al., 2017). Sequential feature elimination
enabled the most extensive feasible exploration of the feature
space, but is computationally expensive and could only be applied
in our study because of the relatively low numbers of features
(225 or less in all analyses). Future studies could attempt classifica-
tion with other data modalities such as VBM or multiple estimates
of connectivity between brain regions. Because feature counts in
these modalities are typically very large, alternative classification
methods could include neural network classifiers, minimum redun-
dancy maximum relevance (mRMR) feature selection, or recursive
feature elimination (Ramírez-Gallego et al., 2017; Sanz, Valim,
Vegas, Oller, & Reverter, 2018; Vieira, Pinaya, & Mechelli, 2017).
5 | CONCLUSION
We explored a range of classification approaches with brain morpho-
metric and white matter integrity measures, and were able to achieve
cross-validation accuracies up to 75% in the small sample with
formally-defined current MDD. The core contribution of our study is
that these results could not be replicated in a comparatively very large
community-based sample with self-reported depression. High classifi-
cation accuracies were also not replicated in larger samples with
remitted or lifetime-experienced MDD. Previous studies largely
focused on small samples with formal diagnoses for current depres-
sion. Our results complement this literature and suggest that it may
not be possible to accurately detect community-based depression in
large samples with structural brain measures. Future studies could
examine whether high accuracies can be achieved in larger samples
with formally diagnosed and more severe MDD (for example, long-
term psychiatric outpatients), and explore other feature domains such
as task-related fMRI and brain connectivity.
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form, and proposals are reviewed by the Generation Scotland Access
Committee. Data from the UK Biobank resource is available for health-
related research upon registration and application through the UK
Biobank Access Management System (https://www.ukbiobank.ac.uk/
register-apply/).
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